These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 23435542)

  • 1. Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseases.
    Salmon M; Luttmann MA; Foley JJ; Buckley PT; Schmidt DB; Burman M; Webb EF; DeHaas CJ; Kotzer CJ; Barrett VJ; Slack RJ; Sarau HM; Palovich MR; Lainé DI; Hay DW; Rumsey WL
    J Pharmacol Exp Ther; 2013 May; 345(2):260-70. PubMed ID: 23435542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchodilator activity of (3R)-3-[[[(3-fluorophenyl)[(3,4,5-trifluorophenyl)methyl]amino] carbonyl]oxy]-1-[2-oxo-2-(2-thienyl)ethyl]-1-azoniabicyclo[2.2.2]octane bromide (CHF5407), a potent, long-acting, and selective muscarinic M3 receptor antagonist.
    Villetti G; Pastore F; Bergamaschi M; Bassani F; Bolzoni PT; Battipaglia L; Amari G; Rizzi A; Delcanale M; Volta R; Cenacchi V; Cacciani F; Zaniboni M; Berti F; Rossoni G; Harrison S; Petrillo P; Santoro E; Scudellaro R; Mannini F; Geppetti PA; Razzetti R; Patacchini R; Civelli M
    J Pharmacol Exp Ther; 2010 Dec; 335(3):622-35. PubMed ID: 20805306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of aclidinium bromide, a novel inhaled muscarinic antagonist, with long duration of action and a favorable pharmacological profile.
    Gavaldà A; Miralpeix M; Ramos I; Otal R; Carreño C; Viñals M; Doménech T; Carcasona C; Reyes B; Vilella D; Gras J; Cortijo J; Morcillo E; Llenas J; Ryder H; Beleta J
    J Pharmacol Exp Ther; 2009 Nov; 331(2):740-51. PubMed ID: 19710368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical evaluation of long-acting muscarinic antagonists: comparison of tiotropium and investigational drugs.
    Casarosa P; Bouyssou T; Germeyer S; Schnapp A; Gantner F; Pieper M
    J Pharmacol Exp Ther; 2009 Aug; 330(2):660-8. PubMed ID: 19478135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo pharmacological characterization of TD-4208, a novel lung-selective inhaled muscarinic antagonist with sustained bronchoprotective effect in experimental animal models.
    Pulido-Rios MT; McNamara A; Obedencio GP; Ji Y; Jaw-Tsai S; Martin WJ; Hegde SS
    J Pharmacol Exp Ther; 2013 Aug; 346(2):241-50. PubMed ID: 23685545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Influence of receptor kinetics on the onset and duration of action and the therapeutic index of NVA237 and tiotropium.
    Sykes DA; Dowling MR; Leighton-Davies J; Kent TC; Fawcett L; Renard E; Trifilieff A; Charlton SJ
    J Pharmacol Exp Ther; 2012 Nov; 343(2):520-8. PubMed ID: 22854200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vitro and in vivo profile of aclidinium bromide in comparison with glycopyrronium bromide.
    Gavaldà A; Ramos I; Carcasona C; Calama E; Otal R; Montero JL; Sentellas S; Aparici M; Vilella D; Alberti J; Beleta J; Miralpeix M
    Pulm Pharmacol Ther; 2014 Aug; 28(2):114-21. PubMed ID: 24928173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel quaternary ammonium derivatives of (3R)-quinuclidinol esters as potent and long-acting muscarinic antagonists with potential for minimal systemic exposure after inhaled administration: identification of (3R)-3-{[hydroxy(di-2-thienyl)acetyl]oxy}-1-(3-phenoxypropyl)-1-azoniabicyclo[2.2.2]octane bromide (aclidinium bromide).
    Prat M; Fernández D; Buil MA; Crespo MI; Casals G; Ferrer M; Tort L; Castro J; Monleón JM; Gavaldà A; Miralpeix M; Ramos I; Doménech T; Vilella D; Antón F; Huerta JM; Espinosa S; López M; Sentellas S; González M; Albertí J; Segarra V; Cárdenas A; Beleta J; Ryder H
    J Med Chem; 2009 Aug; 52(16):5076-92. PubMed ID: 19653626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiotropium bromide (Ba 679 BR), a novel long-acting muscarinic antagonist for the treatment of obstructive airways disease.
    Barnes PJ; Belvisi MG; Mak JC; Haddad EB; O'Connor B
    Life Sci; 1995; 56(11-12):853-9. PubMed ID: 10188785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SB 202026: a novel muscarinic partial agonist with functional selectivity for M1 receptors.
    Loudon JM; Bromidge SM; Brown F; Clark MS; Hatcher JP; Hawkins J; Riley GJ; Noy G; Orlek BS
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1059-68. PubMed ID: 9399977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the muscarinic receptor subtype(s) mediating contraction of the guinea-pig lung strip and inhibition of acetylcholine release in the guinea-pig trachea with the selective muscarinic receptor antagonist tripitramine.
    Roffel AF; Davids JH; Elzinga CR; Wolf D; Zaagsma J; Kilbinger H
    Br J Pharmacol; 1997 Sep; 122(1):133-41. PubMed ID: 9298539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human colon cancer cell proliferation mediated by the M3 muscarinic cholinergic receptor.
    Frucht H; Jensen RT; Dexter D; Yang WL; Xiao Y
    Clin Cancer Res; 1999 Sep; 5(9):2532-9. PubMed ID: 10499630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of imidafenacin (KRP-197/ONO-8025), a new anti-cholinergic agent, on muscarinic acetylcholine receptors. High affinities for M3 and M1 receptor subtypes and selectivity for urinary bladder over salivary gland.
    Kobayashi F; Yageta Y; Segawa M; Matsuzawa S
    Arzneimittelforschung; 2007; 57(2):92-100. PubMed ID: 17396619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regulation of bronchial tone in chronic obstructive pulmonary disease (COPD): role of muscarinic receptors].
    Abad Santos F; Novalbos J; Gallego Sandín S; Gálvez Múgica MA
    An Med Interna; 2003 Apr; 20(4):201-5. PubMed ID: 12768836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective antagonism activity of alkaloids from bulbs Fritillariae at muscarinic receptors: functional studies.
    Lin BQ; Ji H; Li P; Jiang Y; Fang W
    Eur J Pharmacol; 2006 Dec; 551(1-3):125-30. PubMed ID: 17027747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological properties of revefenacin (TD-4208), a novel, nebulized long-acting, and lung selective muscarinic antagonist, at human recombinant muscarinic receptors and in rat, guinea pig, and human isolated airway tissues.
    Hegde SS; Pulido-Rios MT; Luttmann MA; Foley JJ; Hunsberger GE; Steinfeld T; Lee T; Ji Y; Mammen MM; Jasper JR
    Pharmacol Res Perspect; 2018 Jun; 6(3):e00400. PubMed ID: 29736245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylcholine-induced proliferation of fibroblasts and myofibroblasts in vitro is inhibited by tiotropium bromide.
    Pieper MP; Chaudhary NI; Park JE
    Life Sci; 2007 May; 80(24-25):2270-3. PubMed ID: 17412366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional selectivity of muscarinic receptor antagonists for inhibition of M3-mediated phosphoinositide responses in guinea pig urinary bladder and submandibular salivary gland.
    Nelson CP; Gupta P; Napier CM; Nahorski SR; Challiss RA
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1255-65. PubMed ID: 15140916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic characterization of GSK-961081 (TD-5959), a first-in-class inhaled bifunctional bronchodilator possessing muscarinic receptor antagonist and β2-adrenoceptor agonist properties.
    Hegde SS; Hughes AD; Chen Y; Steinfeld T; Jasper JR; Lee TW; McNamara A; Martin WJ; Pulido-Rios MT; Mammen M
    J Pharmacol Exp Ther; 2014 Oct; 351(1):190-9. PubMed ID: 25100753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo.
    Hegde SS; Choppin A; Bonhaus D; Briaud S; Loeb M; Moy TM; Loury D; Eglen RM
    Br J Pharmacol; 1997 Apr; 120(8):1409-18. PubMed ID: 9113359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.